[EN] RETROVIRAL PROTEASE INHIBITING COMPOUNDS<br/>[FR] COMPOSES INHIBANT DES PROTEASES RETROVIRALES
申请人:ABBOTT LABORATORIES
公开号:WO1994014436A1
公开(公告)日:1994-07-07
(EN) A retroviral protease inhibiting compound of formula (A) is disclosed.(FR) L'invention se rapporte à un composé inhibant des protéases rétrovirales, qui est présenté par la formule (A).
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
公开了一种化学式为##STR1##的逆转录病毒蛋白酶抑制剂。
Intermediate for making retroviral protease inhibiting compounds
申请人:Abbott Laboratories
公开号:US05696270A1
公开(公告)日:1997-12-09
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
公开一种化合物,其化学式为##STR1##,可抑制反转录病毒蛋白酶。
Process for making retroviral protease inhibiting compounds
申请人:Abbott Labortories
公开号:US05892052A1
公开(公告)日:1999-04-06
A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
公开了一种化学式为##STR1##的逆转录病毒蛋白酶抑制剂。
COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
申请人:Wang Tao
公开号:US20080119480A1
公开(公告)日:2008-05-22
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.